PATENT CLAIM ANALYSIS

Application Number: 16351457
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "312000"]

Abstract:
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, U, V, Z, W 1 , W 2 , W 3 , and R 1 -R 6  are described herein.

Claim (Index 10):
The compound of  claim 8 , wherein R 1  is chloro.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.31111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15568051', '15964812', '14858170', '15977512', '14858174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7948332417069325
- 35 USC 102 Novelty (BERT): 0.557338730368021
- Combined Prediction Score: 0.7710837905730413
- Mean Citation Score: 397.399702
- Max Citation Score: 410.06107
- Similarity Product: 359.18064260493463

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test